2-Methoxy-N-{4-Methoxy-6-[(1H-Pyrazol-1-Yl)Methyl]-1,2-Benzoxazol-3-Yl}Benzene-1-Sulfonamide

2 trials 1 recruiting

Filter these 2 trials by condition, phase, country and more.

Open in Search →

2 Registered trials

1 Recruiting

0 Completed trials

2 Sponsors

14 Countries

Phase III

Phase II

Phase III: 1 Phase II: 1

Indications tested

Hormone receptor positive HER2 negative breast cancer 2 Breast cancer metastatic 1

Sponsors using this IMP

Pfizer Inc. 1 Unicancer 1

All trials

2 total

Clinical trial evaluating the biological activity of a new drug identified as prifetrastat (PF-07248144), combined with fulvestrant for the … Pending

2025-521982-29-00 Phase II 1 country Unicancer
A Study to Learn About the Study Medicine Called PF-07248144 in Combination with Fulvestrant in People with HR-positive, HER2-negative Advan… Recruiting

2025-520566-22-00 Phase III 14 countries Pfizer Inc.

Showing 1–2 of 2 trials

← All drugs A–Z